Longduoduo Co Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Longduoduo Co Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2022	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	0.41	3.24	3.82	7.39	4.26	1.82
Cost of revenue	0.09	1.01	0.59	0.17	0.09	0.02
Gross profit	0.32	2.23	3.23	7.22	4.17	1.81
Selling, general and administrative	0.7	9.79	3.2	5.19	3.62	2.44
Operating expenses		0.06	0.06	0.09	0.13	0.1
Operating income	-0.38	-7.56	0.03	2.03	0.55	-0.63
Other non-operating income	0	-0.01	0	-0.14	0.16	0.06
Pre-tax income	-0.38	-7.56	0.03	1.89	0.71	-0.58
Income tax		0	0.01	0.52	0.22	0.07
Net income to minority interests	-0.05	-0.05	0.06	0.11	0.03	-0.06
Net income	-0.38	-7.56	-0.04	1.26	0.46	-0.58
EBITDA	-0.38	-7.49	0.1	2.13	0.69	-0.52
EPS, basic	-0.02	-0.29	-0.00	0.04	0.02	-0.02
EPS, diluted	-0.02	-0.29	-0.00	0.04	0.02	-0.02
Shares, basic (weighted)	16.3	25.6	30	30	30	30
Shares, diluted (weighted)	16.3	25.6	30	30	30	30

Balance sheet

	FY2022	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	0.27	0.36	1.14	1.4	1.64	1.59
Inventory		0	0
Other current assets	0.01	0.03	0.07	0.12	0.13	0.14
Total current assets	0.36	0.42	1.31	1.66	1.81	1.78
Property, plant and equipment	0.07	0.11	0.15	0.35	0.28	0.21
Lease right-of-use assets	0.09	0.08	0.01	0.05	0.03	0.07
Intangible assets			0
Total assets	0.51	0.61	1.48	2.06	2.13	2.06
Accounts payable	0.18	0.04	1.04	0.36	0.4	0.4
Accrued liabilities	0.12	0.13	0.09	0.05	0.05	0.05
Deferred revenue	0.44	0.79	0.59	0.71	0.34	0.79
Total current liabilities	0.86	1.63	2.05	1.26	0.83	1.28
Lease liabilities	0.04	0	0.01	0.02		0.02
Total liabilities	0.9	1.63	2.05	1.28	0.83	1.31
Paid-in capital	-0.16	6.86	7.25	7.25	7.25	7.25
Retained earnings	-0.33	-7.85	-7.89	-6.63	-6.17	-6.75
Other comprehensive income	-0.01	0.02	0.07	0.06	0.08	0.17
Shareholders' equity	-0.33	-0.93	-0.54	0.7	1.18	0.7
Minority interests	-0.05	-0.09	-0.03	0.08	0.11	0.05
Total equity	-0.39	-1.02	-0.57	0.78	1.3	0.76
Total liabilities and equity	0.51	0.61	1.48	2.06	2.13	2.06
Shares outstanding	16.3	30	30	30	30	30

Cash flow statement

	FY2022	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-0.38	-7.56	0.02	1.36	0.49	-0.64
Depreciation and amortization	0	0.07	0.07	0.1	0.14	0.11
Stock-based compensation		6.74	0.38
Change in inventory		-0	0	0
Change in payables	0.12	0.01	1.05	-0.69
Cash from operations	0.35	0.03	0.97	0.58	0.28	-0.16
Capital expenditures	-0.07	-0.11	-0.12	-0.31	-0.06	-0.03
Cash from investing	-0.07	-0.11	-0.13	-0.31	-0.06	-0.03
Stock issued		0.03
Cash from financing		0.18	-0.14
Exchange rate effect	-0.01	-0.01	0.08	-0.01	0.02	0.14
Net change in cash	0.27	0.08	0.78	0.27	0.24	-0.05
Free cash flow	0.28	-0.08	0.85	0.28	0.22	-0.19
Income taxes paid		0	0.01	0.52	0.23	0.08

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $0.51 on October 22, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	99.1%	Gross profit / revenue.
Operating margin	-34.7%	Operating income / revenue.
EBITDA margin	-28.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-31.6%	Pre-tax income / revenue.
Net margin	-31.8%	Net income / revenue.
FCF margin	-10.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-8.9%	Cash from operations / revenue.
Return on equity (ROE)	-61.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-27.6%	Net income / average total assets.
SG&A / revenue	133.8%	Selling, general and administrative expense / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	6.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-57.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-21.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	34.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-56.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-17.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	41.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-214.6%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-175.7%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-225.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-226.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-158.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-188.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-40.6%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-3.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	32.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	13.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.39x	Current assets / current liabilities.
Quick ratio	1.24x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.24x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	63.4%	Total liabilities / total assets.
Working capital	$501.4K	Current assets - current liabilities.
Tangible book value	$703.7K	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.87x	Revenue / average total assets.
Fixed asset turnover	7.39x	Revenue / average property, plant and equipment.
Days payables	8,646 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$0.02	Net income per basic share, as reported (split-adjusted).
Revenue per share	$0.06	Revenue / diluted weighted shares.
FCF per share	-$0.01	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.01	Cash from operations / diluted weighted shares.
Book value per share	$0.02	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.02	Tangible book value / shares outstanding.
Cash per share	$0.05	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$15.3M	Share price x shares outstanding.
Enterprise value	$13.7M	Market cap + total debt - cash - short-term investments.
P/S	8.40x	Market cap / revenue.
P/B	21.8x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	21.8x	Market cap / tangible book value, when positive.
EV/Sales	7.53x	Enterprise value / revenue.
FCF yield	-1.3%	Free cash flow / market cap.
Earnings yield	-3.8%	Net income / market cap (the inverse of P/E).

What was Longduoduo Co Ltd's revenue in fiscal 2026?

Longduoduo Co Ltd reported revenue of $1.8M for fiscal 2026, 57.2% lower than the year before.

Was Longduoduo Co Ltd profitable in fiscal 2026?

No. It reported a net loss of $578.6K.

How much free cash flow did Longduoduo Co Ltd generate in fiscal 2026?

Cash from operations of $163.1K minus capital expenditures of $30.6K left free cash flow of -$193.7K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Longduoduo Co Ltd